USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis

USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis - Hallo friendsTHE LEK NEWS, In the article you read this time with the title USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article culture, Article economy, Article health, Article healthy tips, Article news, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis
link : USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis

Read too


USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis

(USA) New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds 

By Russel Davis

December 13, 2017

Image: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds


(Natural News) The U.S. Food and Drug Administration (FDA) recently approved a digital pill embedded with a sensor designed to inform physicians whether their patients are taking their medications. The federal approval marks a growing trend towards addressing drug non-adherence among patients, according to a New York Times report.

The pill, called Abilify MyCite, is a modified version of Otsuka Pharmaceutical’s drug Abilify that is used in the treatment of schizophrenia, bipolar disorder, and depression. It is equipped with a small tracking device developed by Proteus Digital Health. The new tracking pill works by transmitting a message from the sensor to a wearable patch, which then sends data to a mobile app to enable patients to monitor drug ingestion on their smartphone.
Patients who agree to taking the tracking pill can sign consent forms that allow their health care providers and up to four other people including their family members to receive information about the date and time that the drugs are ingested. The technology is currently not approved for patients suffering from dementia-related psychosis.

“The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers,” says Mitchell Mathis of the FDA’s Center for Drug Evaluation and Research.

A 2014 report by the World Health Organization (WHO) reveals that as much as 50 percent of patients on prescription medications fail to take their drugs as instructed. In fact, psychiatric medicine practitioners note that taking medications between 70 and 80 percent of the time is already considered ‘good’ adherence. Experts add that noncompliance costs as much as $100 billion annually as patients only get sicker and spend more on additional treatments and hospitalizations.

FDA approval may exacerbate paranoia in patients, experts warn

The latest FDA approval has been met with ethical concerns, especially among the psychiatric circle. The American Psychiatric Association has stressed the importance of balance between psychiatric care and patient privacy. Likewise, an expert has cautioned that the new tracking pill may boost drug adherence but may also be doomed to backfire due in part to trust issues. Dr. Peter Kramer, a psychiatrist and the author of “Listening to Prozac,” also warns that the new technology seems coercive despite being technically ethical. (Related: Talk to the voices: Unconventional yet obvious ways to heal schizophrenia and average mental mayhem.)

“Psychotic disorders are often characterized by some degree of paranoia, often reaching delusional proportions, in which patients may believe that outside forces are trying to monitor and control them, including controlling minds or bodies or harm them in some way. The idea that we’re giving this group of patients a pill that, in fact, transmits info about them from inside their body to the people that are involved in their treatment almost seems like a confirmation of the worst paranoias of the worst patients,”  says Dr. Paul Appelbaum, director of law, ethics and psychiatry at Columbia University’s psychiatry department.

Sources include: 




Tanks to URL: http://ift.tt/2jbFU8Y ...

Most Viewed Articles



Please respect all credits.

This author archives:




Discernment is recommended.

All articles are of the respective authors and/or publishers responsibility. 

No religious or political belief is defended here.

Individually you can be helped to find your Truth that is different of everyone. 


More @ http://ift.tt/1N5eGmL and 
http://ift.tt/2mJks7C





Like this! please bookmark. It is updated daily









  geoglobe1





Thus Article USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis

That's an article USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis with the link address https://theleknews.blogspot.com/2017/12/usa-new-fda-approved-trackable-pill.html

Subscribe to receive free email updates:

0 Response to "USA: New FDA-approved “trackable” pill transmits information — it will tattle on you if you don’t take your meds ~ Russel Davis"

Post a Comment